Multiple Active Site Corrections for Docking and Virtual Screening

Journal of Medicinal Chemistry

Volumn 47, Issue 1, 2004, Pages 80-89

  Vigers, Guy P A ^a   Rizzi, James P ^a  

^a ARRAY BIOPHARMA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND;

ARTICLE; COMPUTER PROGRAM; CRYSTAL; EXPERIMENT; SCORING SYSTEM; SCREENING; STATISTICAL ANALYSIS; TECHNIQUE;

BINDING SITES; CRYSTALLOGRAPHY, X-RAY; DATABASES, FACTUAL; ENZYME INHIBITORS; LIGANDS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, MOLECULAR; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN BINDING; PROTEIN-TYROSINE-PHOSPHATASE; PROTEINS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; STATISTICS;

EID: 0346731233     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030161o     Document Type: Article

References (42)

1. Kuntz, I. D.; et al. A Geometric Approach to Macromolecule-Ligand Interactions. J. Mol. Biol. 1982, 161, 269-288.
2. Morris, G. M.; et al. Automated docking using a lamarckian genetic algoritm and an empirical binding free energy function. J. Comput. Chem. 1998, 19, 1639-1662.
3. Rarey, M.; et al. A Fast Flexible Docking Method Using an Incremental Construction Algorithm. J. Mol. Biol. 1996, 261, 470-89.
4. FRED, Openeye Software Inc., Santa Fe, NM.
5. Glide, Schrodinger Inc.
6. Jones, G.; et al. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 1997, 267, 727-748.
7. McMartin, C.; Bohacek, R. Powerful, rapid computer algorithms for structure-based drug design. J. Comput.-Aided Mol. Des. 1997, 11, 333-344.
8. Bissantz, C., Folkers, G.; Rognan, D. Protein-based Virtual Screening of Chemical Databases. 1. Evaluation of Different Docking/Scoring Combinations. J. Med. Chem. 2000, 43, 4759-4767.
9. Toledo-Sherman, L. M.; Chen, D. High-throughput virtual screening for drug discovery in parallel. Curr. Opin. Drug Discovery Dev. 2002, 5 (3), 414-421.
10. Broughton, H. B. A method for including protein flexibility in protein-ligand docking: Improving tools for database minimg and virtual screening. J. Mol. Graphics 2000, 18, 247-304.
11. Clausen, H.; et al. FlexE: Efficient molecular docking considering protein structure variations. J. Mol. Biol. 2001, 308, 377-395.
12. Waszkowycz, B. Structure-based approaches to drug design and virtual screening. Curr. Opin. Drug Discovery Dev. 2002, 5 (3), 407-413.
13. Muegge, I.; Martin, Y. C. A general and fast scoring function for protein-ligand interactions: A simplified approach. J. Med. Chem. 1999, 42, 791-804.
14. Muegge, I.; et al. Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein. J. Med. Chem. 1999, 42, 2498-2503.
15. Sybyl, Tripos Inc.
16. Charifson, P. S.; et al. Consensus Scoring: A Method for Obtaining Improved Hit Rates from Docking Databases of Three-Dimensional Structures into Proteins. J. Med. Chem. 1999, 42, 5100-5109.
17. Stahl, M.; Rarey, M. Detailed analysis of scoring functions for virtual screening. J. Med. Chem. 2001, 44, 1035-1042.
18. Kollman, P. A. Advances and continuing challenges in achieving realistic and predictive simulations of the properties of organic and biological molecules. Acc. Chem. Res. 1996, 29, 461-469.
19. Huo, S.; et al. Molecular dynamics and free energy analyses of Cathepsin D-inhibitor interactions: Insight into structure-based ligand design. J. Med. Chem. 2002, 45, 1412-1419.
20. Pearlman, D. A.; Charifson, P. S. Are free energy calculations useful in practice? A comparison with rapid scoring functions for the p38 MAP Kinase protein system. J. Med. Chem. 2001, 44, 3417-3423.
21. Berman, H. M.; et al. The protein data bank. Nucleic Acids Res. 2000, 28, 235-242.
22. CCDC, CCDC/Astex dataset.
23. MDDR, MDL/Prous Scientific Inc.
24. Pargellis, C. A.; et al. Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nature Struct. Biol. 2002, 9 (4), 268-272.
25. Pearlman, R. S. Concord user's manual; Tripos Inc., St. Louis, MO.
26. McGovern, S. L.; et al. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J. Med. Chem. 2002, 45, 1712-1722.
27. Wilson, K. P.; et al. Crystal structure of p38 mitogen-activated protein kinase. J. Biol. Chem. 1996, 271 (44), 27696-27700.
28. Tong, L.; et al. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nature Struct. Biol. 1997, 4 (4), 311-316.
29. Wilson, K. P.; et al. The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Chem. Biol. 1997, 4, 423-431.
30. Pannifer, A. D. B.; et al. Visualization of the cysteinyl-phosphate intermediate of a protein-tyrosine phosphatase by X-ray crystallography. J. Biol. Chem. 1998, 273, 10454-10462.
31. Elchebly, M.; et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1b gene. Science 1999, 283, 1544-1548.
32. Andersen, H. S.; et al. 2-(oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatases. J. Biol. Chem. 2000, 275 (10), 7101-7108.
33. Iversen, L. F.; et al. Structure-based design of a low molecular weight, nonphosphorous, nonpeptide, and highly selective inhibitor of protein-tyrosine phosphatase 1b. J. Biol. Chem. 2000, 275 (14), 10300-10307.
34. MySQL, MySQL Inc.
35. Pan, Y.; et al. Consideration of molecular weight during compound selection in virtual target-based database screening. J. Chem. Inf. Comput. Sci. 2003, 43, 267-272.
36. Blake, J. F.; Laird, E. R. Recent advances in virtual ligand screening. Annu. Rep. Med. Chem. 2003.
37. Clark, R. D.; et al. Consensus scoring for ligand/protein interactions. J. Mol. Graphics 2002, 20, 281-295.
38. Terp, G. E.; et al. A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities. J. Med. Chem. 2001, 44, 2333-2343.
39. Bellon, S.; et al. The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation. Structure 1999, 7, 1057-1065.
40. Eldridge, M. D.; et al. Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J. Comput.-Aided Mol. Des. 1997, 11, 425-445.
41. Stahl, M.; Bohm, H.-J. Development of filter functions for protein-ligand docking. J. Mol. Graphics 1999, 16, 121-132.
42. Nissink, J. W. M.; Verdonk, M. L.; Klebe, G. Simple knowledge-based descriptors to predict protein-ligand interactions. Methodology and validation. J. Comput.-Aided Mol. Des. 2000, 14, 787-803.